VOLITIONRX LTD

VNRX · XNYS

CIK 93314fmd_0MTC270Z0KKGVDS647M94QJSDDManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2026, 63 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.